Quote:
Originally Posted by Bert Jones
Are you a flack for a Pharma industry association?
|
No. In fact, I hate a lot of their practices.
Quote:
Originally Posted by Bert Jones
You seem to believe the premise that the government is laying the groundwork to pass some bill for an industry giveaway to beg them to make antibiotics.
|
This isn't a matter of believing in a premise. Re-read the Orphan drug link.
Pharma will NOT invest in treatments that won't cover the cost of R&D plus production costs. PERIOD. That's a fact, not a premise that needs to be believed in. If a disease has only 100 victims per year, no one will invest 100 million to develop a cure or treatment. Those 100 victims will not be able to cover the cost and the pharma company is guaranteed to lose money.
So, you only have TWO choices:
1) the pharma companies do NOTHING about the rare orphan disease and invest their money in more common diseases that will return a profit; OR
2) Government induces pharma to search for a cure for the rare disease by agreeing protect the pharma company by paying the costs of its R&D. Their is no begging involved.
That's it. There are no other options. But if you think there is, then please explain how you can get a pharma company to spend money on a sure-fire loser without the government guaranteeing them a profit.
Again, that is NOT welfare. The government wants the pharma company to perform some service it will not otherwise do voluntarily. So, the government has to PAY for that service.
Antibiotics present a similar dilemma to orphan drugs. Although far larger numbers of people will need antibiotics, there are currently cheap antibiotics that still work. So the profit margins for new anitbiotics may be razor thin or non-existent. So pharma won't pursue it unless government underwrites losses.
Quote:
Originally Posted by Bert Jones
I just think they should pay their own way, but I bet that your way will prevail.
|
What do you mean by "pay their own way"? They ARE paying their own way when they make a profit by spending their R&D money on diseases that affect a lot of people. That's how they stay in business.
You want them to voluntarily lose money by spending R&D on rare disease. How does that qualify as "paying their own way"?
Quote:
Originally Posted by Bert Jones
I still assert it is just another way to get on the government gravy train, but unneeded for such wealthy companies.
|
It's not a gravy train. It is a money losing venture. So government underwriting of losses IS needed to get the pharma companies to do it.